Patent · US Active

Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

US11428694B2 · kind B2 · utility

0Cited by
118References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 15, 2021
Grant dateAug 30, 2022
Priority date—
Expiry dateApr 15, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.